Search Results

There are 1360 results for: content related to: Mirtazapine protects against cisplatin-induced oxidative stress and DNA damage in the rat brain

  1. You have free access to this content
    Mirtazapine versus other antidepressive agents for depression

    Intervention Review

    The Cochrane Library

    Norio Watanabe, Ichiro M Omori, Atsuo Nakagawa, Andrea Cipriani, Corrado Barbui, Rachel Churchill and Toshi A Furukawa

    Published Online : 7 DEC 2011, DOI: 10.1002/14651858.CD006528.pub2

  2. You have free access to this content
    Mirtazapine: only for depression?

    Acta Neuropsychiatrica

    Volume 18, Issue 3-4, June/August 2006, Pages: 130–143, Luis San and Belen Arranz

    Version of Record online : 21 SEP 2006, DOI: 10.1111/j.1601-5215.2006.00143.x

  3. Pharmacokinetics of Mirtazapine: Enantioselective Effects of the CYP2D6 Ultra Rapid Metabolizer Genotype and Correlation with Adverse Effects

    Clinical Pharmacology & Therapeutics

    Volume 81, Issue 5, May 2007, Pages: 699–707, J Brockmöller, I Meineke and J Kirchheiner

    Version of Record online : 28 FEB 2007, DOI: 10.1038/sj.clpt.6100116

  4. Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of α2-adrenergic and serotonin2C receptors: a comparison with citalopram

    European Journal of Neuroscience

    Volume 12, Issue 3, March 2000, Pages: 1079–1095, M. J. Millan, A. Gobert, J. -M. Rivet, A. Adhumeau-Auclair, D. Cussac, A. Newman-Tancredi, A. Dekeyne, J. -P. Nicolas and F. Lejeune

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1460-9568.2000.00982.x

  5. Ameliorating effects of mirtazapine on visceral hypersensitivity in rats with neonatal colon sensitivity

    Neurogastroenterology & Motility

    Volume 22, Issue 9, September 2010, Pages: 1022–e267, J. Yin, W. Wang, J. H. Winston, R. Zhang and J. D. Z. Chen

    Version of Record online : 26 MAY 2010, DOI: 10.1111/j.1365-2982.2010.01526.x

  6. Efficacy and tolerability of mirtazapine in treating major depressive disorder with anxiety symptoms: an 8-week open-label randomised paroxetine-controlled trial

    International Journal of Clinical Practice

    Volume 65, Issue 3, March 2011, Pages: 323–329, J. E. Kim, S. J. Yoon, J. Kim, J. Y. Jung, H. S. Jeong, H. B. Cho, E. Shin, I. K. Lyoo and T. S. Kim

    Version of Record online : 14 FEB 2011, DOI: 10.1111/j.1742-1241.2010.02624.x

  7. You have free access to this content
    Influence of Mirtazapine on the Hypotensive Activity of Enalapril and Propranolol in Spontaneously Hypertensive Rats

    Basic & Clinical Pharmacology & Toxicology

    Volume 103, Issue 5, November 2008, Pages: 450–454, Dariusz Andrzejczak, Katarzyna Kocon and Remigiusz Zięba

    Version of Record online : 11 AUG 2008, DOI: 10.1111/j.1742-7843.2008.00310.x

  8. A fast, sensitive and simple method for mirtazapine quantification in human plasma by HPLC-ESI-MS/MS. Application to a comparative bioavailability study

    Biomedical Chromatography

    Volume 26, Issue 11, November 2012, Pages: 1399–1407, Ney Carter Borges, Rafael Eliseo Barrientos-Astigarraga, Carlos Eduardo Sverdloff, José Luiz Donato, Patricia Moreno, Leila Felix, Paulo Alexandre Rebelo Galvinas and Ronilson Agnaldo Moreno

    Version of Record online : 16 FEB 2012, DOI: 10.1002/bmc.2711

  9. You have free access to this content
    Newer generation antidepressants for depressive disorders in children and adolescents

    Intervention Review

    The Cochrane Library

    Sarah E Hetrick, Joanne E McKenzie, Georgina R Cox, Magenta B Simmons and Sally N Merry

    Published Online : 14 NOV 2012, DOI: 10.1002/14651858.CD004851.pub3

  10. Effects of low-dose mirtazapine on driving performance in healthy volunteers

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 5, September 2013, Pages: 523–528, Kunihiro Iwamoto, Naoko Kawano, Kazumi Sasada, Kunihiro Kohmura, Maeri Yamamoto, Kazutoshi Ebe, Yukihiro Noda and Norio Ozaki

    Version of Record online : 30 JUN 2013, DOI: 10.1002/hup.2327

  11. More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial

    Human Psychopharmacology: Clinical and Experimental

    Volume 25, Issue 6, August 2010, Pages: 431–438, Viacheslav Terevnikov, Jan-Henry Stenberg, Marina Joffe, Jari Tiihonen, Mark Burkin, Evgueni Tchoukhine and Grigori Joffe

    Version of Record online : 18 AUG 2010, DOI: 10.1002/hup.1137

  12. You have free access to this content
    Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression

    Psychiatry and Clinical Neurosciences

    Volume 62, Issue 1, February 2008, Pages: 75–83, Sung-Wan Kim, Il-Seon Shin, Jae-Min Kim, Young-Chul Kim, Kyu-Sik Kim, Ki-Min Kim, Su-Jin Yang and Jin-Sang Yoon

    Version of Record online : 13 FEB 2008, DOI: 10.1111/j.1440-1819.2007.01778.x

  13. Studies on the pharmacokinetics and pharmacodynamics of mirtazapine in healthy young cats

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 34, Issue 4, August 2011, Pages: 388–396, J. M. QUIMBY, D. L. GUSTAFSON, B. J. SAMBER and K. F. LUNN

    Version of Record online : 24 OCT 2010, DOI: 10.1111/j.1365-2885.2010.01244.x

  14. Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache

    European Journal of Neurology

    Volume 14, Issue 2, February 2007, Pages: 187–193, L. Bendtsen, L. Buchgreitz, S. Ashina and R. Jensen

    Version of Record online : 23 JAN 2007, DOI: 10.1111/j.1468-1331.2006.01607.x

  15. Real-world, open-label study to evaluate the effectiveness of mirtazapine on sleep quality in outpatients with major depressive disorder

    Asia-Pacific Psychiatry

    Volume 6, Issue 2, June 2014, Pages: 152–160, Dan Wang, Zexuan Li, Lingjiang Li and Wei Hao

    Version of Record online : 25 FEB 2013, DOI: 10.1111/appy.12060

  16. Does use of tetracyclic antidepressant—mirtazapine reduce cancer risk in depression patients?

    Pharmacoepidemiology and Drug Safety

    Volume 22, Issue 12, December 2013, Pages: 1292–1297, Li-Min Sun, Ming-Chia Lin, Ji-An Liang, Yen-Jung Chang, Shih-Ni Chang, Fung-Chang Sung, Chih-Hsin Muo and Chia-Hung Kao

    Version of Record online : 20 SEP 2013, DOI: 10.1002/pds.3523

  17. You have free access to this content
    Transfer of the antidepressant mirtazapine into breast milk

    British Journal of Clinical Pharmacology

    Volume 63, Issue 3, March 2007, Pages: 322–327, J. H. Kristensen, Kenneth F. Ilett, 1,2 Jonathan Rampono, 3 Rolland Kohan and 4 L. Peter Hackett 2

    Version of Record online : 13 SEP 2006, DOI: 10.1111/j.1365-2125.2006.02773.x

  18. Neuroendocrinological Mechanisms of Actions of Antidepressant Drugs

    Journal of Neuroendocrinology

    Volume 19, Issue 3, March 2007, Pages: 213–226, C. Schüle

    Version of Record online : 14 DEC 2006, DOI: 10.1111/j.1365-2826.2006.01516.x

  19. Saliva levels of 3-methoxy-4-hydroxyphenylglycol and clinical efficacy of mirtazapine or selective serotonin reuptake inhibitors in patients with major depression

    Human Psychopharmacology: Clinical and Experimental

    Volume 28, Issue 1, January 2013, Pages: 7–14, Maki Egami, Yoshiomi Imamura, Hiromi Nabeta, Yoshito Mizoguchi and Shigeto Yamada

    Version of Record online : 5 NOV 2012, DOI: 10.1002/hup.2273

  20. Mirtazapine does not improve sleep disorders in Alzheimer's disease: results from a double-blind, placebo-controlled pilot study


    Francisca M. Scoralick, Luciana L. Louzada, Juliana L. Quintas, Janeth O.S. Naves, Einstein F. Camargos and Otávio T. Nóbrega

    Version of Record online : 27 JAN 2016, DOI: 10.1111/psyg.12191